A Phase 1, randomised, open-label, two-period, single dose, crossover study to evaluate the safety, tolerability and pharmacokinetics of JZP-110 in healthy subjects under fed and fasted conditions

Trial Profile

A Phase 1, randomised, open-label, two-period, single dose, crossover study to evaluate the safety, tolerability and pharmacokinetics of JZP-110 in healthy subjects under fed and fasted conditions

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs JZP 110 (Primary)
  • Indications Hypersomnia; Narcolepsy; Sleep apnoea syndrome
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 29 Sep 2017 New trial record
    • 01 Sep 2017 Results published in the Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top